NVE Corporation is a high-quality, high-margin niche semiconductor business, but the stock's rich valuation, elevated leverage, and dividend safety warning temper the otherwise strong fundamental profile.
Thesis pillars
- Expensive Valuation↑Improving
- High Quality High Roe Business↓Deteriorating
- Leverage Penalty Flagged↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 5, 2026, based on the 10-K filed May 6, 2026
NVE Corporation (NVEC) Stock Analysis
Temporary headwind edge
Technology · Semiconductors
Hold if already holding. Not a fresh buy at $82.37, but acceptable to hold if already in. Reason: Market cap $399M below $400M minimum.
NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical and factory-automation applications, operating its own U.S. wafer fabrication and test facility in Minnesota. The company relies on several large customers,... Read more
Hold if already holding. Not a fresh buy at $82.37, but acceptable to hold if already in. Reason: Market cap $399M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $399M below $400M minimum. Not in investable universe. Score 4.6/10, moderate confidence.
Passes 4/8 gates (news events none recent, earnings proximity 83d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and clean insider activity. Suitability: aggressive.
About NVE Corporation
About NVE Corporation
NVE Corporation manufactures spintronic sensors, couplers and MRAM memory devices, relying on several large customers, including Abbott Laboratories, distributors and private-brand partners, for a significant percentage of revenue as of its March 31, 2026 fiscal year end. The Minnesota-based company, founded in 1989, has been awarded more than $50 million in government research contracts since inception and employed 42 people, 40 of them full-time, as of fiscal year end.
NVE earns revenue from three product lines: magnetic sensors used in factory automation, robotics and implantable medical devices; couplers that electrically isolate and transmit data between electronic subsystems in power conversion and industrial networking applications; and low-bit-density MRAM aimed at military, industrial and antitamper markets. The company operates its own front-end wafer fabrication and back-end testing facility, which it considers an advantage over competitors that outsource manufacturing, though most of its device packaging services take place in Asia. NVE sells through distributors including America II Electronics, Angst+Pfister Sensors and Power, and Digi-Key, supplemented by private-brand partnerships with large integrated device manufacturers.
Show full overview
NVE announced on June 22, 2026 that President and CEO Daniel A. Baker will retire effective at the August 6, 2026 annual meeting, to be succeeded by Peter Eames, the company's Vice President of Advanced Technology since 2016, with Baker remaining as Board chairman pending shareholder approval. The leadership change comes as the company continues to disclose reliance on several large customers, including Abbott Laboratories, for a significant percentage of revenue, a concentration the 10-K says could materially harm results if one or more of these customers were lost.
See also: Technology · Semiconductors
From NVE Corporation's most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-10-29Recent Developments — NVE Corporation
Latest news
- NEWS NVE Corp (NVEC) CEO sells 20,000 shares after exercising options - Stock Titan — Stock Titan negative
- NEWS NVE Corp (NVEC) CEO sells 20,000 shares after exercising options - stocktitan.net — stocktitan.net negative
- NEWS NVE (NVEC) Q1 2027 earnings summary - Quartr — Quartr neutral
- NEWS Is NVE Corp (NVEC) Showing Value After Q2 Results? GF Score: 73/100, Revenue Declines by 8% - GuruFocus — GuruFocus negative
- NEWS NVE Corp (NVEC) Tops Q2 EPS by 85c - StreetInsider — StreetInsider positive
Generated 2026-10-29T11:53:51Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerAbbott Laboratories and other large customers10-K Item 1: 'We rely on several large customers for a significant percentage of our revenue, including Abbott Laboratories, certain distributors, and certain other customers.'
- MEDIUMSupplierpackaging services in Asia10-K Item 1: 'We have worldwide wafer sources; most of our packaging services take place in Asia.'
Material Events(8-K, last 90d)
- 2026-06-22Item 5.02MEDIUMNVE Corporation announced CEO Daniel A. Baker will retire effective at the August 6, 2026 annual meeting, succeeded by Peter Eames, currently VP of Advanced Technology; Baker will remain Board chairman, a clean planned handoff.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Revenue shrinking — -8.1% YoY. Growth thesis broken unless recovery story develops.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $82.37, but acceptable to hold if already in. Reason: Market cap $399M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $399M below $400M minimum. Not in investable universe. Resistance target $115.30 (+40.0%), stop $76.60 (−7.5%), A.R:R 0.0:1. Score 4.6/10, moderate confidence.
Resistance target: $115.30 (+40.0% upside). Resistance target $115.30 (+40.0%), stop $76.60 (−7.5%), A.R:R 0.0:1. Stop-loss: $76.60.
Market cap $399M below $400M minimum.
NVE Corporation trades at a P/E of 22.3 (forward 29.1). TrendMatrix value score: 3.5/10. Verdict: Hold.
6 analysts cover NVEC with a consensus score of 2.2/5.
What does NVE Corporation do?NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical...
NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical and factory-automation applications, operating its own U.S. wafer fabrication and test facility in Minnesota. The company relies on several large customers, including Abbott Laboratories, distributors and private-brand partners, for a significant percentage of its revenue, and had 42 employees as of March 31, 2026, its fiscal year end.